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Hold fast to dreams, for if dreams die,  
life is a broken-winged bird that cannot fly. 
 
Langston Hughes
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ABSTRACT 
From embryonic development to tissue regeneration and disease progression, the 
human body is continuously subject to mechanical stresses. Physical forces are 
increasingly recognized as major microenvironmental cues that control tensional 
homeostasis in tissues. Cells constantly receive and translate physical cues into 
biological messages, which in turn dictate cell shape, state and function. While much is 
known about biochemical signaling, many of the mechanisms that drive cell outcome in 
response to biophysical influences remain to be uncovered.   
 Here we have investigated biophysical regulation of cell function. The goal was 
to gain a deeper understanding of fundamental principles that govern cell behavior in 
response to physical stimuli. To carefully recapitulate signaling in the in vivo 
microenvironment, we utilized a battery of tools that stem from the field of 
bioengineering. We used conjugated polymers to develop a novel neural stem cell 
culture substrate with anchored growth factors to promote cell self-renewal. Upon an 
electrochemical switch, growth factor presentation was reversed, which initiated 
cellular differentiation along the neuronal lineages. This electroactive material allowed 
for temporal control of growth factor presentation, increased growth factor stability and 
a closer reflection of biological signaling during brain development in vivo.  
 In addition to temporal changes in growth factor presentation, mechanical 
stiffness of tissues is also dynamically altered over time. Cells sense and respond to the 
mechanics of their substrate - be it the extracellular matrix, neighboring cells or 
artificial matrix in cell culture. Using biologically relevant elastic substrates to study 
cell function in vitro has proven beneficial, as the in vivo microenvironment usually is 
much softer than rigid plastic dishes. Stiffened tumor stroma is a hallmark of cancer 
and understanding mechanosensitive pathways involved in the onset of cancer is key in 
identifying strategies for cancer treatment. We have therefore investigated the role of 
matrix stiffness in Notch signaling in breast cancer cells. This signaling pathway is a 
highly conserved cell-to-cell communication system that regulates cell fate in 
development and disease. Aberrant Notch signaling in breast cancer has been found to 
correlate with invasion and patient outcome. Our results show that we can tune cell 
stiffness and migration by regulating Notch activity and matrix stiffness. We propose 
an opportunity to target the cancer cell/microenvironment interface instead of the Notch 
pathway itself in the development of cancer therapies. 
 Finally, we have studied the role of nanoarchitecture of ephrin ligands in Eph 
receptor activation. Eph/ephrin signaling is a cell-to-cell communication pathway, 
which regulates cell migration and proliferation. Dysregulation of this pathway has 
been associated with a multitude of human diseases, including breast cancer. Here, we 
developed a new tool based on DNA origami, which allows for precise positioning of 
ephrin ligands on DNA at the nanoscale. We found that Eph receptor activation and 
downstream events are regulated by ephrin spatial distribution. This work contributes to 
our understanding of how physical cues in the form of ligand presentation impact breast 
cancer cell behavior. Ultimately, elucidating the mechanisms involved in biophysical 
regulation of cell function is necessary to understand cellular dysfunction and diseases.  
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INTRODUCTION 
THE CELLULAR MICROENVIRONMENT 
Cellular functions are carefully orchestrated by signals present in the microenvironment. 
These signals include growth factors and cytokines, the extracellular matrix, oxygen and 
calcium levels as well as cell-cell interactions. Together, these signals act in a tightly 
controlled manner over space and time to provide stimuli that regulate key functions, 
such as cell survival, proliferation and differentiation.  
 Direct signaling between cells and the extracellular matrix or between neighboring 
cells in tissues is a key mechanism by which cells receive cues that direct their state and 
fate. These interactions are largely mediated by specialized receptor proteins present in 
the cell membrane. Activation of receptors is dependent on the presence and binding of 
ligands, which initiates a sequence of molecular switches that transduce a signal from 
the exterior to the interior of the cell. Ligands are often soluble molecules secreted by 
cells that can act both locally and over long distances. Tethered ligands, however, 
require direct physical contact, either between cells and the extracellular matrix or 
between juxtaposed cells. Ligands bind specifically to the extracellular domain of the 
receptor, usually triggering a conformational change in the intracellular domain of the 
receptor, which attracts signaling proteins or activates enzymatic activity in the 
receptor itself. The transduced signal is often amplified, producing multiple intracellular 
messages. Ultimately, a message conveyed to the inside of the cell mediates a 
physiological response that regulates cell function. 
 Throughout the lifetime of a higher-order organism, cells receive and translate 
external mechanical cues into biological messages, which dictate cell form, fate or 
function. While biochemical signals in the cellular microenvironment have been 
extensively investigated, studies regarding the effects of mechanical signals were for a 
long time neglected. Nevertheless, the human body is continuously subject to forces, 
from innate forces, such as gravity, to those induced by exercise and movement, 
resulting in stretching and relaxing of tissue. As such, mechanical stresses are constantly 
present on a cellular level and it is now widely accepted that they are major conductors 
in the regulation of cell function. For instance, when microenvironmental forces are 
applied to cells, cells have to meet force with resistance. This force balance is a 
fundamental mechanism in maintaining tensional homeostasis, part of the 
microenvironmental yin and yang of cells and tissues.  
 In my thesis work, I have investigated signaling pathways that rely on direct 
physical contact, in the context of biophysical regulation. Below I will describe these 
pathways, and later, their relevance in development and disease. The common strategy 
in each of the systems studied was to recapitulate signals present in the in vivo 
microenvironment to better understand their influence on cell function. Each study was 
designed to answer fundamental biological questions using cell engineering approaches 
and resorting to a broad array of materials and technologies. 
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FGF SIGNALING 
Fibroblast growth factors (FGF) are polypeptide ligands that execute their actions by 
binding to tyrosine kinase receptors. These receptors regulate key cellular functions 
ranging from germ cell maturation and development to homeostasis and tissue repair. 
Dysregulation of the FGF signaling pathway has been well documented in many 
diseases, including developmental disorders and cancer.1 The 18 mammalian secreted 
FGFs share a common core region of 120-140 amino acids, which are divided into 
subfamilies based on their sequence similarities in their amine (N-) and carboxy (C-) 
terminals.2 The four different fibroblast growth factor receptors (FGFR1-FGFR4) are 
single-pass transmembrane receptors with a split tyrosine kinase domain in the 
intracellular part of the receptor and three immunoglobulin-like domains in the 
extracellular region. A fifth receptor, FGFR5, lacks the intracellular tyrosine kinase 
domain and is less understood.3 Moreover, tissue specific alternative splicing events, 
both of the ligands and receptors, generate increased ligand-receptor specificity. 
 FGF ligands have a heparan sulfate glycosaminoglycan binding site and are 
readily sequestered to heparan sulfates in the extracellular matrix (ECM). Heparan 
sulfates are long chains of repeating disaccharide units, chemically similar to heparin, 
and are components of the ECM, where they augment in FGF-FGFR binding. 
Specifically, the negatively charged heparin sulfates form a complex with canonical 
FGF, which then facilitate FGFR dimerization by binding to the positively charged 
lysines and arginines present in the heparin binding sites on the ligands.4 Variation in the 
sequence of receptor, ligand and heparan sulfate leads to a diverse range of binding 
between these molecules, which ultimately gives rise to high biological diversity.5,6 
Importantly, heparan sulfate glycosaminoglycans act as a storage reservoir for FGF and 
stabilize the ligand against degradation.7 Dimerization of the FGF/FGFR/heparan sulfate 
complex leads to a conformational change of the intracellular domain of the receptors, 
which initiates transphosphorylation of the tyrosine kinase domain and C-terminal. This 
process then activates subsequent downstream signaling pathways, such as the Ras, Akt 
or the protein kinase C pathways.1 The work presented here focused on FGF2, also 
known as basic FGF. FGF2 is involved in synaptic formation, inflammation and neuron-
glia interaction.8 It is also involved in defining rostro-caudal identity in the neural tube 
during development.9 Importantly, FGF2 is a neurogenic factor that regulates neural 
stem cell proliferation and differentiation through its interaction with FGFR1, both 
during development and in the adult.  
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NOTCH SIGNALING 
The Notch signaling pathway is an evolutionary conserved signaling system present in 
all metazoans, mediating cell fate choices by direct cell-cell contact through proteins on 
cell membranes. It is clear from the literature that this pathway is significant in the 
development, homeostasis and pathology of all three germ layers and their derivatives. 
Ligand-receptor binding triggers Notch receptor proteolysis, and unlike most other 
signaling pathways, the released intracellular receptor domain translocates into the 
nucleus, where it is physically involved in gene expression activation. Despite being a 
molecularly relatively simple signaling system, the Notch pathway elicits very diverse 
responses that vary over time and space in a cell context-dependent manner. Due to the 
repeated use of the Notch signaling pathway throughout the lifespan of an organism, 
disruption thereof has shown diverse and severe effects. As such, developing mice with 
defective Notch signaling show general growth retardation and embryonic lethality 
before E10.5.10 Moreover, Notch dysregulation is associated with multiple diseases, 
including cancer, where it can act either as an oncogene or as a tumor suppressor 
depending on the cellular context, again reflecting the versatility of the Notch signaling 
system.11  
 The Notch signaling pathway includes a series of catalytic events of the receptor 
that ultimately leads to transcriptional regulation. The Notch receptor first undergoes 
furin cleavage at the S1 site in the trans-Golgi network by a convertase, resulting in a 
heterodimeric protein that is recruited to the plasma membrane. The single-pass Notch 
receptor (Notch 1-4 in mammals) consists of an intracellular PEST domain on the C-
terminal, a transcription activation domain (TAD), two nuclear localization signals 
(NLS) flanking the six ankyrin (ANK) repeats, a RBP-J Associated Molecule (RAM) 
domain and a transmembrane domain that connects the intracellular domain to the 
extracellular domain. The extracellular region consists of a heterodimerization domain 
(HD), three cysteine rich LIN-12-Notch repeats (LNR) and 29-36 EGF-like repeats, 
repeat 11 and 12 being necessary for ligand binding.12 LNR and HD make up the 
negative regulatory region (NRR), which is unmasked upon ligand binding.  
 Notch binds any of the five canonical ligands, Jagged (JAG1 and JAG2) or Delta-
like (DLL1, DLL3, DLL4) on juxtaposed cells. Ligand binding is followed by two 
catalytic steps: A Disintegrin and Metalloprotease (ADAM) cleaves the receptor 
extracellularly (S2 cleavage) and gamma-secretase cleaves the receptor within the 
transmembrane domain (S3 cleavage), liberating the Notch intracellular domain 
(NICD).13,14 The NICD then translocates into the cell nucleus where it binds the DNA-
binding protein CSL (CBF1, Suppressor of Hairless, Lag-1; also known as RBP-J"). In 
the absence of Notch signaling, CSL functions as a transcriptional repressor, together 
with corepressors such as CtBP, HDAC and Hairless. However, upon NICD binding to 
CSL, repressors are released and coactivators, including Mastermind-like1 and histone 
acetyltransferases HAT/p300, are recruited to the transcription complex, which initiates 
transcription of Notch target genes,15 as shown in Figure 1. Immediate target genes of 
active Notch signaling are the basic helix-loop-helix proteins (bHLH) Hes and Hey, 
which in turn function as transcriptional repressors. Other target genes, for example of 
relevance to cancer, are the cell cycle associated genes Myc, cyclin-D1 and p21, as well 
as genes linked to epithelial-mesenchymal transition, such as Slug.16 Moreover, Notch 
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activates its own expression and that of its ligands, as well as transcription of its own 
negative regulators Notch-regulated ankyrin repeat protein (Nrarp) and Deltex-1, 
providing an intrinsic negative feedback loop.17,18,19  
 While endocytosis generally functions as a means to down-regulate receptor 
signaling, the Notch signaling system instead requires endocytosis for pathway 
activation and downregulation of the receptor. However, endocytosis is not only 
necessary in the receptor-expressing cell, but notably, the ligand must also be 
endocytosed into the signaling cell for Notch to be activated in the receiving cell.20 For 
years, the mechanistic connection between ligand endocytosis and receptor activation 
remained unclear, until it was demonstrated that ligand-receptor binding creates a 
physical pulling force that reveals the NRR and allows ADAM to cleave at the S2 site, a 
prerequisite for S3 cleavage and release of the NICD.21 The requirement for a 
biomechanical force in Notch signaling activation has sparked a hypothesis that Notch is 
in fact mechanosensitive. Therefore, Notch signaling in mechanosensing has received 
increasing attention, for instance in the fields of angiogenesis and blood formation. 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 1. Notch signaling. (A) Upon ligand binding, the Notch receptor is cleaved by ADAM at the S2 
site, followed by cleavage by S3 #-secretase in the cell membrane. The liberated active NICD translocates 
to the nucleus, where corepressors (CoR) are released and NICD binds to the DNA-binding protein CLS 
with coactivators (CoA), which initiates transcritption. (B) The Notch receptor consists of an intracellular 
PEST, TAD, two NLSs, an ANK domain, a RAM domain and a transmembrane domain. The extracellular 
part of the receptor consists of a HD, three LNR and 29-36 EGF-like repeats, where 11 and 12 are 
necessary for ligand binding. LNR and HD make up the NRR, which protects S2 from cleavage in the 
absence of ligand.  
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EPH/EPHRIN SIGNALING 
Receptor tyrosine kinases (RTKs) are one type of ligand-dependent cell membrane 
receptors with intrinsic enzymatic activity, which is involved in development and 
disease. Erythropoietin--‐producing hepatocellular carcinoma (Eph) receptors are the 
largest class of RTKs and bind specifically to their corresponding ephrin ligands. The 
Eph/ephrin cell--‐to--‐cell communication pathway is involved in many embryonic 
developmental processes, including axon guidance, cell migration and the formation of 
tissue boundaries. Moreover, Eph/ephrin signaling is also involved in adult tissue 
homeostasis, for instance by regulating proliferation and migration of progenitor cells in 
the intestine, one of few adult tissues with a highly proliferative stem cell pool.22 
Dysregulation of this pathway has been implicated in many forms of cancer. 
Interestingly, Eph/ephrin signaling has shown both tumor suppressing and tumor 
promoting characteristics, depending on the tumor type and stage. These 
observations are in line with the complexity of this signaling pathway in normal 
tissue. 
 Eph receptors are divided into two classes: EphA and EphB. There are nine 
different mammalian EphAs and five different EphBs. EphAs bind one of the six 
mammalian ephrinA ligands, whereas EphBs preferentially bind one of the three 
ephrinBs, although some cross-class interaction is also known to occur. Eph receptors 
are single-pass transmembrane proteins consisting of an intracellular PDZ domain-
binding site, a sterile alpha motif (SAM) domain and a tyrosine kinase domain, which is 
linked to the plasma membrane through a juxtamembrane region. In the extracellular 
domain of the receptor there are two fibronectin-type III repeats, a cystein rich domain 
and the ligand-binding domain. The ephrins consist mainly of the Eph binding domain 
in their extracellular region. While ephrinB has an intracellular region with a PDZ 
domain, the ephrinA ligands are glycophosphatidylinositol-linked proteins and lack an 
intracellular domain.23 
 Binding of ephrins to the receptors induces transphosphorylation by the kinase 
domains of the tyrosine residues on the intracellular domains of Eph. Two conserved 
phosphorylation sites on tyrosine residues in the juxtamembrane domain of the receptor 
are of particular importance, since they release the auto-inhibitory interaction between 
the juxtamembrane and the kinase domain. This allows the receptor to take on a more 
stable and active conformation, thus enabling further phosphorylation of tyrosine 
residues on the kinase domain, as illustrated in Figure 2. Some of these phosphorylated 
tyrosines recruit signaling molecules containing src-homology2 (SH2) domains.24,25 
Other signaling molecules that are recruited to the receptor complex are guanine 
nucleotide exchange factors for Rho family GTPases (GEFs) and PDZ domain-
containing proteins. The different signaling proteins recruited upon kinase activity will 
mediate various downstream signaling cascades and cell functions, for example cell 
migration through RhoA or RhoG via the GEF Ephexin.26  
 In contrast to other common ligand-receptor signaling systems, Eph/ephrin 
interaction activates both forward and reverse signaling, meaning that signaling 
cascades can be triggered both in the receptor--‐expressing cell (forward signaling) as 
well as in the ligand--‐expressing cell (reverse signaling). Reverse signaling involves 
phosphorylation of the ephrinB cytoplasmic tail by Src family kinases, and recruitment 
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of signaling effectors. However, reverse signaling through EphrinA, which lacks a 
cytoplasmic domain, requires the association of transmembrane signaling partners, such 
as p75 or Trk/B, to trigger phosphorylation of Src family kinases and phosphoinositide 
3-kinases.27 Eph/ephrin bi-directional signaling is a well-studied phenomenon and is a 
key mechanism behind many known functions, such as axon migration and growth 
cone collapse, as well as spine and synapse formation.28,29,30  
To build upon this complexity, receptor clustering is key in transmitting a
downstream signal. Ephrin ligands usually form clusters in the cell membrane of the 
signaling cell, which cross-links Eph receptors on neighboring cells. This is in contrast 
to several other RTKs, in which the ligand has to bind simultaneously to only two 
receptors. Thus, soluble recombinant monomeric ephrin ligands are inefficient in 
activating the Eph receptor. Instead, to activate forward Eph signaling and study 
downstream responses in vitro, ephrin-Fc fusion proteins are clustered with an anti-Fc 
antibody, which creates higher-order ephrin clusters. Whereas recombinant 
extracellular ephrin-Fc fusion proteins that interfere with endogenous Eph/ephrin 
binding can be used to block reverse signaling, extracellular Eph-Fc fusion proteins can 
be used to stimulate reverse signaling, and simultaneously block Eph forward 
signaling. The ability to induce receptor activation in one direction, while inhibiting the 
other, is of great interest in the development of cancer therapeutics that target the 
Ehp/ephrin signaling pathway. 
 
 
 
 
 
 
  
Figure 2. Eph/ephrin signaling. (A) Eph receptors binding to ephrin ligands on opposing cells initiates 
receptor clustering and autophosphorylation of tyrosine residues in the intracellular receptor domain.  
(B) The intracellular domain of the Eph receptor consists of a PDZ binding domain, a SAM domain, the 
tyrosine kinase domain and a juxtamembrane domain. The extracellular domain of the receptor has two 
fibronectin-type III repeats, a cystein rich domain and the ligand-binding domain. 
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MECHANOTRANSDUCTION 
Mechanical stresses are ever present in the microenvironment and influence form and 
growth of every cell and tissue, from gastrulation to organ regeneration. Forces are key 
in the most fundamental functions of our bodies, such as heartbeat, the circulatory 
system and in muscles, tendons and bones. On a smaller scale, mechanical forces exist 
as main components in the cellular microenvironment and drive basic cellular functions, 
including proliferation, differentiation, adhesion, migration and apoptosis. Cells 
constantly feel and respond to their immediate surrounding, whether it is a cell culture 
dish, nearby cells or matrix. In fact, the ECM was long viewed as a scaffolding structure 
which main function was to maintain tissue morphology, and that the cells in this 
scaffold received information from their environment in the form of chemical cues, like 
growth factors and cytokines. Today it is well understood that cells are poised to 
respond to mechanical stimuli arising in the microenvironment, such as the ECM, which 
in fact is a highly dynamic and versatile structure. Moreover, cells themselves generate 
internal forces by contractility that regulate essential cell functions, such as chromosome 
rearrangement during mitosis, organelle transport and migration. Whereas much is 
known about the chemical signals that influence cell state, less is known about the 
physical cues and how these are translated, or transduced, into biological information. 
Mechanotransduction refers to the process used by cells to respond to their three-
dimensional (3D) environment. Specifically, it is the mechanism by which cells convert 
mechanical cues in their surrounding to biochemical signals, which in turn steer cell 
function through gene expression or other cell behavior. The role of forces in tissue 
remodeling and development was studied already in 1892 and gave rise to Wolff's law, 
which states that the form and function of bones are in direct correlation to the stress 
imposed upon them. However, it is only with recent development of new technologies 
that this field has generated such great attention and insight into the biomechanics of 
cells and tissue. 
 Cells have highly dynamic and complex machinery that regulates intracellular 
forces. The cytoskeleton, consisting of a coordinated network of microtubules, 
intermediate filaments and actin filaments, constitutes a crucial part of this machinery. 
Actin makes up the actin cortex, a thin filament layer just beneath the plasma membrane 
that provides mechanical support. Together with non-muscle myosin II, actin generates 
cell contractility forming the actomyosin network that connects various regions of the 
cell membrane, as well as the membrane to the nucleus.31 Furthermore, the intracellular 
actin cytoskeleton is physically linked to transmembrane integrins that bind specific 
peptide sequences, like RGD, in the ECM on the outside of the cells. Upon application 
of force, integrins cluster with adaptor proteins to form focal adhesions, which are large 
protein multicomplexes that provide points of adhesion between cells and the ECM. 
Importantly, forces that arise in the ECM create stress on the focal adhesions when the 
actin cytoskeleton applies an opposing force from the inside of the cell. The same 
applies in the reverse direction: forces generated inside the cell create stress on the focal 
adhesions resulting in an opposite, reactive force in the ECM. Cells in a soft 
microenvironment with a pliable ECM fail to develop mature focal adhesions.32 
Similarly, transmission of an applied force is inhibited when contractility through 
myosin is blocked.33  
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 Focal adhesions do not merely provide cell-ECM adhesion, nor does the 
actomyosin network function only to regulate external-internal force balancing. They 
also have the important function of conveying messages to the cells that ultimately 
influence cell form and function. Focal adhesions are thus important biochemical 
signaling centers, containing a large number of adaptor proteins that via stress fibers 
transduce information necessary for proper cell function. Some of these proteins include 
talin, vinculin and paxillin, which physically link the integrins to the actomyosin 
network. Further, maturation of focal adhesions attracts a number of signaling 
molecules, including focal adhesion kinase (FAK), p130Cas, Src, small GTPase Rho, 
ERK and Akt, which trigger phosphorylation and force-induced structural 
rearrangements that initiate signaling transduction and contractility.34,35 Typically, 
phosphorylation of myosin light chain (MLC) by MLC kinase promotes an actin-myosin 
interaction that is balanced by MLC phosphatase. These events are regulated by the 
Rho-effector Rho-associated protein kinase (ROCK), which controls MLC 
phosphorylation levels.  
 A study in which researchers applied nano-Newton forces to individual focal 
adhesions in fibroblasts showed that the application of a minute force resulted in 
relaxation and recovery of contractility in the cell over a longer time period than that of 
the force applied.36 Another study showed that cells pulled harder on an adhesion that 
resisted the cellsÕ pulling forces.37 These results demonstrate how focal adhesions 
regulate a highly dynamic feedback system involving external forces, cytoskeletal 
rearrangements, reinforcement at the site of adhesion and transduction of the signal. 
Importantly, cells constantly produce, remodel and degrade components of the ECM, 
creating a reciprocal relationship between the ECM and cells. The resulting changes in 
the ECM will in turn influence behavior of nearby cells. Additionally to cell-ECM 
interaction and regulation, mechanotransduction between cells work in a similar fashion, 
as cells naturally also pull on their neighbors. Actin-mediated cell-cell contacts are 
formed through the cadherin protein family that make up adherence junctions. Similarly 
to focal adhesions, interaction of cadherins induces myosin II activation, which 
promotes actin stabilization and recruitment of additional cadherins and signaling 
proteins, triggering signal transduction.38 Moreover, stress activates mechanically gated 
ion channels, which decrease or increase ion fluxes upon applied force. 
 From initial biophysical input, through adhesion points, to the cytoskeleton and to 
the final cellular output, there are multiple mechanisms and opportunities for versatility 
in the long chain of events involved in signaling transduction. The heterodimeric 
integrins are formed from an $ and a % subunit and each integrin combination has its 
own binding specificity. Integrins bind several ECM proteins and have specific 
signaling properties. Physical properties of the ECM, including spatial arrangement, 
porosity, topography and stiffness, regulate focal adhesion architecture and subsequent 
recruitment of signaling molecules. Further, actomyosin filaments as well as focal 
adhesions are dynamic complexes with constant protein association and dissociation, 
leading to continuous competition for binding sites between various signaling 
molecules. Force-induced structural rearrangements; posttranslational modifications of 
proteins, such as phosphorylation and de-phosphorylation; and the activity and 
subcellular localization of different key players, such as Rho GTPase, focal adhesion 
kinase, Src family members, mitogen-activated protein (MAP), protein kinase C kinases 
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or integrin-linked kinase, further introduce versatility in the system and the ultimate 
biological outcome. As for every other signaling system in the human body, each of the 
events in the chain of mechanotransduction is under extreme tight regulation and is 
dependent on cell type, location and timing. The rapid recognition of mechosignaling 
has inspired research to identify alternative signaling pathways that are involved in 
mechanotransduction. In this work, we investigate the possibilities of Notch and 
Eph/ephrin signaling being components of mechanosensitive pathways.  
 
 
CELLS CAN FEEL TOO 
 The ECM is a dynamic structure that undergoes constant stiffness changes through 
production, matrix crosslinking and proteolysis during development and disease 
progression. The fact that cells fail to develop mature focal adhesions on soft substrates, 
along with decreased levels of RhoA and FAK, suggest that myosin activity and cellular 
contractility is directly altered by substrate stiffness.39 Furthermore, forced RhoA 
activity in cells on soft substrates promotes a cell phenotype resembling that of a cell 
growing on a stiff substrate. Although not entirely understood, cells are believed to feel 
the elasticity of their surrounding using similar mechanotransduction mechanisms as 
when a force is applied to cells. Interestingly, endogenous cell contractility can be 
modulated without applying external forces by simply changing the mechanical stiffness 
of the substrate against which the cells pull. Scientists have long been making use of 
both natural and synthetic materials to elicit phenotypes that are otherwise hard to 
capture in vitro. Mimicking the natural elasticity of cells and tissue when studying 
mechanotransduction is key since these physical cues are completely lost on rigid 
surfaces. In fact, cell culture dishes are at least a million times stiffer than the softest 
tissues of our body. Generally, cells grown on soft substrates look round with poorly 
arranged stress fibers, whereas cells grown on stiff material polarize and spread, form 
focal adhesions and well-aligned stress fibers.40,41 Cells presented to substrates with both 
soft and stiff areas tend to migrate to the stiffer region, a process called durotaxis.41,42  
 Interestingly, several studies have shown that the proper substrate stiffness can 
directly tune cell state and fate, including maintenance of pluripotency, promotion of 
self-renewal, and direct lineage specification.43Ð45 In particular, differentiation of bone 
marrow derived mesenchymal stem cells (MSCs) cultured on gels of varying stiffness 
was shown to depend on substrate elasticity. In this study, MSCs grown on stiff 
substrates promoted the expression of osteogenic markers, while intermediate substrate 
stiffness induced myogenic differentiation and the softest substrates promoted 
expression of neuronal markers.45 Other work has demonstrated the promotion of 
neuronal maturation on soft substrates, compared to stiffer substrates.46,47 The central 
strategy in these experiments was the same: to match the elasticity of the substrate to the 
in vivo tissue stiffness. These studies demonstrate that biophysical cues regulate cell 
shape, function and fate.  
 In addition to matrix elasticity, there are a multitude of biophysical factors in the 
microenvironment that affect cell function. Although outside the scope of this thesis, 
some examples that demonstrate the role of mechanotransduction in the regulation of 
cell function follow here. In addition to substrate stiffness, cell shape also drives 
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differentiation, as shown for human MSCs grown on micropatterns that allowed for 
control of cell spreading. Here, MSCs on small patterns became adipogenic, whereas 
MSCs on larger patterns became osteogenic. The cell shape-based lineage commitment 
was RhoA dependent, and direct manipulation of RhoA signaling was sufficient to drive 
MSC differentiation in either direction to become fat or bone cells.48 Contact guidance, 
the phenomenon of directional growth of cells along substrate topography, has been 
widely studied on microfabricated patterns, showing that cells tend to elongate and align 
to ridges and grooves at the nanoscale with a dependence on groove width.49,50 This does 
not only have implications in development but also in cancer, where aligned matrices 
are often found near tumors, providing support for migrating cells and promoting tumor 
cell invasion.51 The effect of stress and strain on cell behavior is also well-characterized, 
both in vitro and in vivo, demonstrating the influence of stress and strain on 
development and homeostasis in tissues such as the lungs, kidneys, circulatory system 
and brain.  
 
 
THE TUMOR MICROENVIRONMENT 
WHEN CELLS LOSE TOUCH 
While it is widely recognized that tumor cells receive soluble signals from nearby 
stromal cells, mechanical communication is also crucial for tumor cells. Consequently, 
the biophysical microenvironment plays a crucial role in cancer development and 
progression. When the mechanotransduction machinery is deregulated, for instance by 
mutations in the proteins involved in the downstream signaling pathway, force sensing 
will be altered and tissue homeostasis perturbed. Any other alterations within the cells or 
in the microenvironment, like the ECM, that change the transmission of forces can 
promote decreased or increased signaling transduction and lead to disease. Normal ECM 
function is tightly controlled by several regulatory mechanisms, which ensure proper 
composition and stiffness. A key mechanism is the production and activity of enzymes, 
such as matrix metalloproteases (MMPs), that remodel and break down components of 
the ECM. As such, dysregulation of these potent enzymes during aging or disease 
progression can have destructive consequences. Increased degradation of the ECM 
allows for greater motility of cells that subsequently break away and invade other tissue. 
For instance, matrix metalloprotease expression and activity is elevated in most types of 
cancer and correlates with invasion and metastasis. Moreover, abnormal composition, 
arrangement, topography and amount of ECM can cause, as well as be a cause of 
aberrant cell function. Hence, disorganization, reduced matrix turnover and increased 
matrix deposition are all hallmarks of cancer. 
 Tumors are most often much stiffer than normal tissue due to increased rigidity of 
the matrix. In breast cancer, the stroma has been found to display up to ten times higher 
stiffness compared to healthy tissue, which has been directly coupled with tumor cell 
invasion and progression.52 In vitro, non-transformed mammary epithelial cells cultured 
in soft collagen 3D gels formed polarized, acinar structures, while those cultured in 
stiffer gels lost their polarization and showed an increase in proliferation and 
characteristics of a malignant phenotype.53 Force-dependent aggregation and clustering 
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of integrins led to intensified stabilization of focal adhesions but disrupted adherence 
junctions in a Rho-ROCK-dependent manner. Reducing cellular tension by regulating 
Rho signaling reversed the malignant phenotype and inhibited tumor cell proliferation. 
Other studies have confirmed elevated integrin levels and signaling activity in breast 
cancer cells and similarly to Rho disruption, inhibition of integrin expression through 
genetic ablation resulted in decreased breast malignancy.54 
 
 
SIGNALING IN BREAST CANCER 
The Notch signaling pathway has been linked to many different human cancers. The 
Notch receptor was initially highlighted in humans as an oncogene in T-cell 
lymphoblastic leukemia (T-ALL) and it was later shown that Notch1 has mutations 
resulting in constitutive activity in over 50% of all T-ALL cases.55 Further, ligand-
independent Notch4 ICD expression has been discovered in murine mammary cancers, 
and Notch1 ICD has been shown to induce transformation of mammary epithelial cells 
in vitro.56,57 Active forms of the Notch1 ICD have been found in several human breast 
cancer cell lines, where a decrease in Notch signaling levels reversed the transformed 
phenotype, and conversely, Notch activation in normal mammary epithelial cells 
induced transformation.58 Numb, a key negative regulator of Notch signaling, is lost in 
around 50% of human breast cancers due to degradation. This correlated with tumor 
grade, and cell growth in these tumors could be suppressed by Notch inhibition.59 
Notably, elevated levels of Notch1 and the ligand Jagged1 in breast cancer tumors 
correlates with poor survival.60  
 Similarly to the Notch signaling pathway, Eph/ephrin signaling is also greatly 
implicated in cancer and expression levels of both ligand and receptor are correlated 
with cancer progression and patient outcome. For example, the receptor of interest in 
paper IV, EphA2, is overexpressed in many cancers, particularly in more than 40% of 
breast cancers.61 In a large panel of breast cancer cell lines studied, there was an inverse 
relationship between ligand-receptor expression: expression of EphA2 was inversely 
correlated to the levels of ephrin-A1. Further, EphA2 suppression was induced upon 
ligand expression due to ligand-mediated receptor internalization and degradation. 
Transfection of EphA2 in normal epithelial cells was sufficient to induce transformation 
and further studies suggested that the observed oncogenic potential of EphA2 was 
exerted independently of ligand-induced receptor phosphorylation.62  
 Common for the Notch and Eph/ephrin signaling pathways is that they both can 
act as tumor promoters as well as tumor suppressors. Which of the two mechanisms that 
is used is cell-context dependent. Moreover, crosstalk with other signaling pathways is 
known to be involved in tumor promoting or suppressive functions. Notch has for 
instance been shown to crosstalk with other oncogenic signaling pathways, such as Wnt 
and Hedgehog, as well as with estrogen receptors. EphA2 interacts physically with the 
EGF receptor, which was shown to induce Erk and Rho GTPase activity in a ligand-
independent manner, promoting tumor cell malignancy. On the other hand, EphA2 
stimulation with ephrin-A1-Fc reduced Erk phosphorylation in tumor cell lines and 
inhibited transformation of mouse fibroblast cells.63  
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SIGNALING IN DEVELOPMENT 
NEURAL DEVELOPMENT 
Neurulation is the embryonic developmental process that leads to the formation of the 
neural tube, the precursor of the entire central nervous system (CNS). Neurulation 
involves a carefully orchestrated sequence of events that include induction and 
elongation of the neural plate along the length of the embryo, folding of the neural plate 
and neural tube closure in a zipper-like manner, during which it buds off from the 
overlying ectoderm. The rostral part of the neural tube develops into the forebrain, 
midbrain and hindbrain, whereas the rest of the neural tube forms the spinal cord.  
 When neurulation commences, a single layer of neuroepithelial cells with neural 
stem cell (NSC)-like properties start appearing in the ventricular zone at embryonic day 
(E) 8 in rodents. These cells are highly bipolar, with their apical side attached to the 
ventricle and a basal process stretching to the pial surface. During the expansion phase 
of the stem cell pool, the nuclei migrate in an apico-basal fashion called interkinetic 
nuclear migration, where they stay at the basal lamina during DNA replication and move 
to the apical-most area for cell division. During midgestation, the neuroepithelium 
thickens and the cells maintain their neuroepithelial properties, expressing for example 
the intermediate filament marker nestin. At the same time they become more elongated 
and start expressing astroglial markers, such as brain lipid binding protein (BLBP) and 
glial fibrillary acidic protein (GFAP). These cells are referred to as radial glia and 
undergo repeated asymmetric cell division, during which young neurons migrate 
basally, out of the ventricular zone, along the radial glia. A new germinal layer is 
formed, called the subventricular zone, harbouring proliferative basal progenitor cells. 
These cells maintain their proliferative capacity and make up the pool of neural stem 
cells in the adult. The cerebral cortex of the telencephalon is eventually formed from 
migrating neurons, which give rise to six cortical layers, with the youngest neurons 
found closest to the cortical surface. In the adult, proliferative activity of neural cells is 
limited to the dentate gyrus of the hippocampus and the lateral walls of the lateral 
ventricles. 
 Development of the CNS is an extremely intricate process, during which the cell 
state must be regulated under precise spatial and temporal control. Successful neural 
development is a result of exact coordination of cells' polar organization, cell cycle 
length, regulation by growth factor input, epigenetics, cell communication and so forth. 
These events work in concert to affect cells in a context-dependent manner. Together, 
these regulative mechanisms control cell fate switches, patterning, maintenance of the 
progenitor pool and brain size. 
 Patterning of the body axis occurs through the repeated use of specific molecular 
signaling mechanisms, which relay spatial and temporal information to progenitor cells. 
Just like the rest of the developing embryo, development of the CNS follows tight 
regulatory machinery, controlling the balance and timing of gene expression. For 
instance, morphogen gradients of signaling molecules specify positional identity to 
populations of progenitor domains. In the developing neural tube, cells are exposed to 
two opposing gradients of Wnts/bone morphogenic proteins (BMPs) and Sonic 
Hedgehog (SHH), the combination of which defines distinct progenitor domains in a 
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concentration-dependent manner. Moreover, cells in the developing CNS receive 
patterning information in an anteroposterior fashion, which regionalizes progenitors 
along the length of the body axis. In addition to Wnts, BMPs and SHH, FGFs are 
important in defining positional identity in the developing telencephalon.  
 At least ten different FGFs seem to have a role in brain development, from the 
earliest stages of neural induction to establishment of appropriate connectivity as well as 
in the adult brain. For example, at E9.5-10 of the developing mouse brain, the 
expression of FGF8 and FGF17 is highly regionalized in certain domains rostrocaudally 
in the brain. Further, whereas the two analogues FGF1 and FGF2 both are potent 
mitogens in the developing CNS, FGF2 is expressed in the cortex earlier than FGF1 and 
while FGF2 is expressed both in neuronal and non-neuronal cells, FGF1 expression is 
restricted to neuronal cell types.64  
 Although the focus of the study in this work was FGF signaling in NSCs, the 
approach used here has potential to be applied also with other signaling mechanisms, 
such as Notch or Eph. These pathways are also highly involved in the development of 
the CNS, as briefly described below.  
 The Notch signaling pathway plays a crucial role in making cell fate choices in 
CNS development. At the onset of neurogenesis, Notch inhibits differentiation of 
neurons by expressing the bHLH proteins Hes and Hey, which repress proneural genes, 
such as Neurogenin. However, once a cell acquires lineage commitment, this cells acts 
on its neighboring cells to downregulate the expression of the ligand, thus making 
adjacent cells following different cell fates. The transcriptional feedback that allows for 
Notch to regulate its own expression of both receptor and ligand, described previously, 
is the key mechanism behind pattern formation by lateral inhibition. Lateral inhibition 
thus makes up an important feature of Notch signaling in neural development that leads 
to maintenance of the progenitor pool and specification of cell fate in a population of 
initially homogenous cells. Furthermore, Notch signaling has been implicated in the 
differentiation of glial cells, neurite development and in homeostasis of the adult 
nervous system.65 
 The Eph/ephrin signaling pathway is highly involved in the development of the 
CNS as well. As already mentioned, bi-directional signaling of this pathway is for 
example involved in processes such as axon guidance and formation of synapses. 
Moreover, it has been shown that Ephrin-A2 and EphA7 control cell number in the brain 
by reverse signaling that negatively regulates neural progenitor proliferation.30 Signaling 
through Ephrin-A5 and EphA7 has also been shown to be involved in controlling brain 
size by triggering pro-apoptotic pathways in early cortical progenitors.66,67  
 
 
NEURAL STEM CELLS IN VITRO 
Expansion of stem cell-like progenitors from the developing CNS in vitro offers 
opportunities to study molecular and cellular processes during development and disease. 
The model system used in these studies is an adherent monolayer of NSCs derived from 
the telencephalon from mid-gestation rats. These cells are expanded in serum-free well-
defined media in the addition of the mitogen FGF2, and are immunoreactive for the 
intermediate filament marker nestin. The NSCs have the capacity to differentiate into 
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neurons, astrocytes, oligodendrocytes and smooth muscle cells through stimulation with 
Wnt/BMP4, ciliary neurotrophic factor (CNTF), thyroid hormone (T3) or fetal bovine 
serum/BMP, respectively.68,69 Withdrawal of FGF2 results in spontaneous 
differentiation into astrocytes, neurons and to a lower extent, oligodendrocytes. In the 
presence of FGF2, cells self-renew and maintain their multipotent neural stem cell state. 
Additionally, FGF2 mediates Notch expression, which in turn inhibits neurogenesis.70 
 Multiple strategies to derive NSCs from pluripotent stem cells have been 
established. One such method relies on differentiation of NSCs from mouse embryonic 
stem cells (ESC) in the presence of FGF2 and epidermal growth factor (EGF). Cell lines 
established from these embryonic stem cell-derived neural stem cells (ESC-NSC) divide 
symmetrically and express the radial glia marker BLBP and can give rise to neurons, 
astrocytes and oligodendrocytes in culture.71  
 The 2012 Nobel Prize-winning discovery that adult cells can be reprogrammed to 
an embryonic stem cell-like state, so-called induced pluripotent stem (iPS) cells, has 
further opened up for opportunities to manipulate and recapitulate development in vitro. 
As such, NSC cultures have successfully been derived from iPS cells and importantly, 
this system hold great promise for patient-derived cell cultures to study 
neurodegenerative disease.   
 
 
ENGINEERING THE BIOPHYSICAL MICROENVIRONMENT 
Bioengineers are making use of a large variety of new materials and techniques in the 
quest to understand cell function in development and disease. With the gained interest in 
the field of biophysical cell regulation and mechanotransduction, there is now a vast 
amount of literature on how to develop cell culture substrates of different elasticities, 
how to steer cell fate on such materials and how to acquire certain phenotypes that are 
challenging to derive on rigid plastic dishes. Oftentimes these substrate gels consist of 
varying degrees of crosslinking of a polymer, and one persisting challenge in the field is 
how to change stiffness independently of ECM protein concentration. Additionally, 
tissue elasticity is rarely static but changes with time and disease progression. To 
recapitulate these events, there are protocols to change substrate stiffness during cell 
culture.72,73 
 Though not applied in this thesis work, another exciting method of study in the 
field of cellular bioengineering is 3D cell cultures. Studying cells in two dimensions 
does not reproduce in vivo tissue organization and physiology. Cells naturally exist in 
three dimensions, and in vitro 3D cultures have gained rapidly growing attention. 
Studies in such systems more closely resemble the in vivo scenario, and have generated 
quite different results than observed in traditional two dimensional in vitro studies.52,74   
 Another important cornerstone in the study of cell dynamics is the advent and 
development of high-resolution techniques that allow for investigation of forces on 
small scale. Such techniques include optical tweezers, force spectroscopy and atomic 
force microscopy (AFM), that can be used to measure binding and unbinding events of 
proteins, molecular interactions at the nanoscale in real time and cell membrane 
dynamics in living cells.  
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AIMS 
This work addresses the roles of biophysical variables on signaling through cell-ECM 
and cell-cell communication pathways by utilizing a broad tool kit that includes the 
development of novel technologies. The overall goals of the research presented here 
were to gain a basic understanding of the roles of biophysical variables on the 
mechanisms of cell-ECM or cell-cell interactions. Specifically, the respective studies 
aimed to:  
 
¥ Use a novel cell culture substrate based on conjugated polymers to study the effect of 
dynamic FGF presentation to neural stem cells for maintenance of stem cell 
proliferation and controlled onset of differentiation.  
 
¥ Elucidate the role of substrate stiffness on Notch signaling and cell dynamics in 
highly invasive breast cancer cells and control cell dynamics based on Notch activity. 
 
¥ Develop well-defined ephrin-A5 nano-patterns using DNA origami to investigate the 
role of ligand spatial distribution on Eph receptor activation in invasive breast cancer 
cells.  
  
!
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PAPER I 
Bioelectronics is an interdisciplinary field of research that combines material science 
with biology and electronics. One cornerstone in this research area is conjugated 
polymers. These organic polymers can be in states ranging from semiconductive to 
highly conductive and have commercial uses such as antistatic coatings, solar panels and 
light-emitting diodes. The interface between electronic materials and biology has gained 
huge interest in the field due to the versatility and tunability of these materials. The great 
advantages of the polymers are their ease of processability, mechanical properties and 
importantly, the ability to fine-tune the electrical properties. Conjugated polymers have 
been used to control cell adhesion or neurite outgrowth as well as to deliver ions and 
biomolecules to cells through organic electronic ion pumps.
75,76,77
 We hypothesize that 
conjugated polymers have the potential to be used as a tool in mimicking the in vivo 
cellular microenvironment.  
 Organic conjugated polymers contain alternating single and double bonds between 
the carbon atoms in the polymer backbone, giving rise to a chemical bonding with 
unpaired electrons. This characteristic enables charge mobility: by insertion of positive 
or negative electrical charge, which must be balanced by counterions, the polymers can 
be ÒdopedÓ to become conductive. Importantly, this structure provides a mechanism to 
engineer the polymers to suit specific needs. The properties of conjugated polymers are 
tailored by the synthesis method and the redox state of the polymers. Reversible 
switching between oxidation states of the polymer can alter bulk properties such as 
hydrophobicity, conductivity and volume. For instance, when a negatively charged ion 
is incorporated in the polymer during electrosynthesis and this ion is too large to be 
mobile, a cation will enter the polymer to maintain charge neutrality during 
reduction/undoping, which results in a volume expansion. On the contrary, if the ion is 
small and immobile, it will be released from the polymer upon reduction, resulting in 
polymer contraction.  
 In paper I, we explored the biocompatibility of a commonly used conjugated 
polymer, polypyrrole (PPy), the structure of which is shown in Figure 3. The 
counterions incorporated upon doping of conjugated polymers have critical significance 
for their physical and chemical properties as well as their biocompatibility. Thus, the 
motivation behind this investigation was to identify a PPy-based material that could be 
used in further studies in which we aimed to recapitulate and control the neural stem cell 
microenvironment. PPy has been studied with a wide array of counterions for use in 
neural probes and various kinds of microactuators.
78,79
 
 In this study, we used PPy electropolymerized with four commonly used 
counterions to dope the polymer: dodecylbenzenesulfonate (DBS), tosylate (TsO), 
perchlorate (ClO4) and chloride (Cl). Although these have been used before in neural 
probes and interfaces, they had not been previously tested for biocompatibility with 
primary NSC cultures, which are highly sensitive cell systems. We found that cell 
survival was correlated with the size of the counterion used: NSCs cultured on 
PPy(DBS) survived and proliferated in the presence of FGF2, whereas cell survival on 
PPy(TsO), PPy(ClO4) and PPy(Cl) was minimal.  
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For PPy-based materials to have a relevance in the development of devices or 
microactuators for PPy/NSC interfaces, these cells must not only survive on the doped, 
or pristine, polymer but also upon electrochemical reduction. We found that reduction of 
PPy(DBS) caused a large decrease in cell survival in the cell layer growing on top of the 
polymer. This was prevented when precoating the PPy film with a gel layer of basement 
membrane matrix. We hypothesize that this gel creates a buffering layer that inhibits cell 
death induced by direct or indirect effects of the electrochemical activation of the 
polymer. 
 In conclusion, we identified PPy doped with DBS to make a suitable and 
biocompatible platform for neural stem cell studies. This material is of great interest for 
future development of PPy-based devices due to its reported stability and large volume 
changes capabilities of up to 30-40% of the bulk polymer during redox reactions.
80
  
  
Figure 3. Chemical structures of polypyrrole in the neutral (A) and the doped state (B). 
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PAPER II 
Like paper I, the study in paper II is based on organic bioelectronics. A commonly used 
conjugated polymer in the field is poly(3,4-ethylenedioxythiophene) (PEDOT). 
Similarly to PPy, PEDOT incorporates negatively charged ions during electrosynthesis 
to make up for positive charges that arise along the polymer backbone, as illustrated in 
Figure 4. In addition, it is highly stable and can retain its properties in a broad pH range. 
As PEDOT itself is insoluble, the common use of poly(styrenesulfonate) (PSS) as a 
counterion has great advantages, since it not only renders the polymer soluble, but also 
enhances its conductivity and increases processability. PEDOT:PSS-based materials 
have been extensively explored for use in sensors and transistors, and are highly 
compatible with cell culture.
81
  
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
In this study we aimed to develop a novel substrate for stem cell culture based on 
PEDOT, with the unique feature of controlling growth factor presentation. Stem cell 
culture commonly relies on the sequential addition of mitogens for stem cell 
proliferation. However, as previously described, growth factors in vivo are rarely 
presented to cells in soluble form, but are instead immobilized on other cells or in the 
ECM. The rationale behind this study was to more closely recapitulate this aspect of 
growth factor presentation. Not only does anchored growth factor presentation mimic in 
vivo conditions, but immobilized growth factors have also shown increased protein 
stability and activity compared to growth factors in solution. Moreover, during 
embryonic development, growth factor presentation changes over time, a feature that is 
hard to control in existing growth factor immobilization strategies, which often rely on 
covalent immobilization. 
 Several growth factors, including FGF, naturally bind heparin and heparan 
sulfates. Here we have used the conjugated polymer PEDOT as a means to anchor 
FGF2, and then used these polymer films as cell culture substrates for expansion of 
Figure 4. Chemical structures of PEDOT in the neutral (A) and the doped state (B). 
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NSCs. Since heparin and heparan sulfates are negatively charged molecules, we 
hypothesized that these could be used as counterions in the electrosynthesis of PEDOT. 
Furthermore, we hypothesized that electrochemical reduction of the conjugated polymer 
would cause a switch in growth factor presentation, which would decrease or eliminate 
FGF2 presentation to the NSCs grown on the polymer substrates.  As expected, we 
could demonstrate that FGF2 anchored to PEDOT through heparin supported 
proliferation of NSCs. Importantly, stem cell properties were maintained over four days 
of culture without further FGF2 addition, confirming stabilization of the growth factor. 
In addition, we showed that an electrochemical switch of the polymer substrate triggered 
spontaneous differentiation of the NSCs into astrocytes and neurons, suggesting that the 
presentation of FGF2 was reversed by a simple redox reaction.  
 The tool we developed here more closely mimics the in vivo microenvironment 
during CNS development, where mitogens are presented to cells in an anchored form. 
This allows for stem cell expansion that can be inhibited at any time to induce the onset 
of differentiation. The temporal control of growth factor presentation makes this a 
unique and powerful tool, as does the ability for use with other heparin binding growth 
factors that altogether could broaden our overall knowledge of stem cell science. 
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PAPER III 
Bridging biology and material science to gain a deeper understanding in cellular and 
molecular function is at the forefront of biomedicine. This study sought to understand 
how biophysical attributes in cancerous tissues influence cell state. Matrix stiffness 
regulates cell behavior, which has been demonstrated for a variety of different cell types, 
including stem cells and cancer cells. Though the cell culture dish is a routine tool for 
many cell-based assays, certain physical cues, such as mechanical stimuli exerted on 
cells in their native habitat, are completely lost in standard culture dishes. For this 
reason, it is desirable to use biologically relevant elastic substrates for in vitro cell 
culture in order to investigate how cells respond to their physical environment.  
 While it has been understood that Notch signaling depends on ligand endocytosis 
in the signaling cell, the exact mechanisms behind these events have remained elusive. 
After years of speculation, it was recently shown that Notch signaling activation requires 
an external pulling force applied to the receptor, which exposes the S2 cleavage site for 
metalloproteases. S2 cleavage is a prerequisite for the next cleavage step by gamma-
secretase, which liberates the active NICD. Despite the relative simplicity of the 
pathway, in which the released NICD is physically involved in gene expression 
activation by binding DNA through CSL, transcriptional regulation by Notch is not. 
Rather, it is highly regulated both spatially and temporally. Aberration of the Notch 
signaling pathway has been strongly linked with malignancy. For instance, Notch 
signaling is overactive and required for maintenance of the transformed phenotype in 
human breast cancer. Increased levels of Notch1 and the ligand Jagged1 have been 
observed in human breast cancer, which in turn correlated with poor prognosis.
60,82
  
 The requirement for a physical pulling force on the Notch receptor through ligand 
endocytosis led to speculations that Notch may be mechanosensitive. For instance, 
Notch has been shown to be under the control of integrin !1 during somite border 
formation during embryonic development. As integrins are part of cell-ECM adhesion 
points that transmit forces, these results led to researchers to propose that Notch could 
be crucial for downstream mechanosignaling. The Notch signaling pathway is also 
required for the development of blood vessels. It has been shown that blood flow is 
required for Notch activation suggesting that shear forces exerted in the vasculature 
directly affect Notch signaling. Furthermore, work has shown that Notch regulates nitric 
oxide, a signaling molecule involved in mechanotransduction, in the regulation of 
arterial identity.
83,84
 In light of these accumulating results, we were interested in 
studying Notch signaling in the context of mechanical stiffness sensing. Targeting the 
Notch signaling pathway is of great interest in the search for new therapeutic strategies 
in treating breast cancer. Hence, it is crucial to elucidate the biophysical effects and how 
they influence this signaling pathway. 
 The stiffness of human tissue is highly diverse, ranging from an elastic modulus of 
a few hundred pascal to an order of GPa, as measured for pliable, jello-like brain and 
rigid bone, respectively.
45,85
 However, the onset and progression of disease does not 
only result in biological or functional alterations of tissue, but also structural ones. 
Tumors are much stiffer than normal tissue, due to increased collagen deposition, ECM 
remodeling and abnormal matrix turnover. In breast cancer, the tumor stroma has been 
found to display up to ten times higher stiffness compared to healthy tissue, ranging 
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from 0.1-0.2 kPa in normal mammary glands to 2 kPa in tumorous mammary tissue. 
Stiffened, fibrous tissue, as detected on a mammogram, is a hallmark of breast cancer 
and has been directly coupled with tumor cell invasion and progression.
52
  
 Mechanical changes have also been observed in individual cells during disease 
progression, such as in malaria and cancer.
86
 Thus, it is of great interest to study cell 
mechanics in order to increase our understanding of how structural and mechanical 
characteristics of diseased cells differ from healthy cells. In fact, the investigation of cell 
mechanics is not new. Already in the late 1940s, Francis Crick used magnetic particles 
to study the cytoplasm of chick fibroblasts in culture.
87
 Nowadays, there are many 
powerful techniques in place to measure single-cell mechanics. With recent advances, it 
is now possible to use methods such as microfluidics, optical or laser tweezers or AFM 
to probe mechanical effects on biological structures, from cells to small molecules. 
AFM has also been used to test patient-derived cancer cells and tissue ex vivo, in an 
attempt to establish a mechanical profile of cancer.
88,89
 Learning about cell mechanics in 
diseases like cancer may play pivotal role in the development of therapeutics. 
Additionally, cancer cell mechanical profiles have the potential to be used as biomarkers 
to detect cancer at early stages.   
 While AFM has been extensively used to scan surfaces in material science, it has 
found increasing potential in the field of biology and bioengineering. Force 
spectroscopy using AFM provides single-cell resolution in cell elasticity measurements. 
This is done by probing a living cell with a cantilever sensor that measures the 
mechanical response of the cell upon an applied external force. Specifically, a laser 
beam is focused on top of a cantilever with a small tip at one end. The reflection of the 
laser beam is focused onto a photodiode detector, which detects any bending of the 
cantilever. The cantilever is allowed to move towards an underlying, adherent cell and 
the tip slightly indents the cell and then retracts. Meanwhile, the force and vertical 
deflection of the cantilever is measured, resulting in a force-distance curve. The force-
curve is then used to calculate the cell's elastic modulus, or Young's modulus. In this 
study we have used AFM for single-cell force spectroscopy on the highly invasive breast 
cancer cells MDA-MB-231. Previous elasticity measurements of cancer cells show 
varying results in stiffness compared to normal cells, which indicates an increased need 
for standardization of cell mechanics measurements and further investigations.  
 In line with the overall aim of this thesis work, we have mimicked the 
mechanical properties of the tumor cell microenvironment here. The objective of this 
study was to investigate how biophysical cues in the microenvironment of cancerous 
tissues influence cell state. Also, since it is speculated that Notch is involved in 
mechanosensing, we wanted to learn whether aberrant Notch activity in breast cancer 
correlates with tumor stiffness. Therefore, we used synthetic hydrogels made of 
polyacrylamide as elastic cell culture substrates. The substrates had varying elastic 
moduli of 0.5 kPa, 2 kPa, 4 kPa, 12 kPa and 50 kPa. In addition to gene expression 
analysis, we developed a novel Notch signaling detection method based on an in situ 
proximity ligation assay (PLA) to analyze Notch activation in cells. PLA is a powerful 
technology that extends the capabilities of traditional immunocytochemistry to detect 
single protein events, such as protein-protein interactions or post-translational 
modifications of proteins in cells or in tissue. Two primary antibodies raised in 
different species are used to detect the antigens of interest; in this case anti-NICD and 
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anti-CSL were used. Specific PLA probes, which are species-specific secondary 
antibodies attached to short oligonucleotide strands, bind the primary antibodies. If the 
PLA probes are in close proximity (<40 nm), additional DNA connector probes will 
hybridize and be ligated to form complete DNA circles. These are then amplified 
through rolling circle amplification using a polymerase, followed by hybridization of 
fluorescent probes. The result can be visualized under the microscope as fluorescent, 
round spots, which are easily quantified. The use of the invasive breast cancer cell line 
MDA-MB-231 thus allowed us to link Notch signaling to biophysical properties in a 
malignant breast cancer model. Furthermore, we used AFM to measure cancer cell 
stiffness in relation to substrate stiffness and Notch signaling.  
 We found that Notch activity was associated with the elasticity of the underlying 
substrate, in that Notch levels increased with increasing substrate stiffness. Cell stiffness 
also increased with increasing substrate stiffness, as well as cell migration. Interestingly, 
the stiffness of cells could be tuned by regulating Notch signaling, as shown for cells 
cultured on the softest (0.5 kPa) and stiffest (50 kPa) substrates. Here, cells grown on the 
soft substrates became stiffer upon Notch activation and cells grown on the stiff 
substrates became softer upon Notch inhibition. Moreover, we found that Notch 
inhibition resulted in decreased cell migration on stiff substrates. These results show that 
targeting Notch signaling levels can directly reduce cell stiffness and cell migration. 
 Since a cell looses its innate biomechanical properties as soon as it is uncoupled 
from its native microenvironment, the stiffness of cells measured in culture remains 
conflicting and does not represent in vivo elasticity. In some cases, cancer cells have 
exhibited a reduction in stiffness compared to normal cells from the same tissue.  On the 
other hand, other studies have reported that elastic moduli increase directly with level of 
malignancy.
90
 One explanation could be that cancerous cells may go undergo stiffness 
changes during different stages of cancer, much like how cells undergo stiffness changes 
throughout development. Cells require a highly dynamic actomyosin network for 
migration along the ECM, which contributes to increased tension and stiffer cells. 
However, to invade foreign tissue, one can imagine that a soft and flexible cell would be 
of advantage, in order to squeeze through cell layers and escape.  
 Clinical trials involving the inhibition of Notch signaling are already ongoing in 
patients with advanced breast cancer, but this remains to be further exploited. In this 
study, we aimed to investigate opportunities for cancer therapies that target the cancer 
cell/microenvironment interface instead of the Notch pathway itself. The lower levels of 
Notch observed on soft substrates, together with the fact that a reduction in Notch 
signaling on stiff substrates decreased migration and elasticity, suggest that it may be 
possible to decrease invasiveness of breast cancer cells by directly targeting the tumor 
microenvironment. 
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PAPER IV 
In this study, we made use of a novel technique known as DNA nanotechnology. As the 
name suggests, this method is based on deoxyribonucleic acid, more commonly referred 
to as DNA, which is the basic building block of life and comprises the genetic code in 
all living organisms. DNA exists as a double helix, which is formed by the 
complementary binding between the nucleotide bases thymine and adenine, and 
cytosine and guanine, more simply known as T, A, C and G, respectively. In DNA 
nanotechnology, the naturally occurring base-pair interactions are used as a basic 
principle to  self--‐assemble DNA nanostructures. The idea to use DNA as building 
blocks to construct nano-size objects was pioneered by Nadrian Seeman in 1982, 
thus founding the field of DNA nanotechnology.
91
 This technique took a huge 
step forward in 2006 when Paul Rothemund revolutionized this method by 
introducing a scaffold-based assembly of DNA nanostructures. This kilobase-
long ssDNA, usually from a harmless bacteriophage, is folded into any desired 
shape or pattern by forming complementary base pairing with several hundred 
short, synthetic oligonucleotide strands, referred to as staple strands. Notably, 
the genetic information of the DNA sequences are unimportant, as the nucleotide 
sequences merely are used as building blocks. The work by Rothemund 
presented a variety of two-dimensional sheets, from stars and smiley faces to 
world maps, consisting of a single layer of DNA helices. This technique, called 
DNA origami, was quickly implemented to make complex 3D objects, including 
stacks, spheres and even nanoboxes with lids.
92,93
 Hence, DNA origami has 
enabled highly controlled design and robust and efficient production of 
nanometer sized DNA objects.  
The desire to use DNA origami for biological research has sparked a 
great interest in finding applications for this tool. For instance, DNA origami 
has been used as a nano-ruler for microscopy and to measure distances 
between single molecules.
94
 There is also huge potential for DNA origami to 
be used as drug delivery vehicles, by specifically binding cells and unloading a 
cargo of for example anti-cancer drugs.
95,96,97
 Other work uses DNA origami in 
the study of cell and molecular biology, for example to investigate cytoplasmic 
motor proteins or ion channels.
98,99
  
Our motivation to use DNA origami lies in the unique ability to position 
proteins at precise locations at the nanoscale on the structures. Since the exact 
position of every staple strand is known, these can be functionalized with other 
biomolecules, allowing for nanoscale control over protein positioning on the 
DNA structure. At this point, there exists no other known method that lets 
scientists tailor-make protein-presenting objects in such a highly controlled manner, at 
nanoscale distances and independent of protein concentration. We have designed an 
array of such protein-presenting nanomolecules, of varying proximity and local 
stoichiometry, which have then been presented to cells. The tool we have developed 
is a proof-of-principle that cell signaling can be activated using these protein DNA 
origami structures. More importantly, however, is the identification of functional 
differences in cells upon cell stimulation using this tool. 
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Specifically, we were interested in the Eph/ephrin signaling pathway. As 
previously described, Eph activation depends on the formation of higher order 
clusters of the ephrin ligand. Furthermore, it has been hypothesized that the degree 
and effect of Eph receptor activation is determined by ligand distribution on
juxtaposed cells. Unfortunately, studying microenvironmental factors, such as 
ligand-receptor distribution, remains difficult due to lack of control and resolution 
at the nanoscale. Thus, neither the direct regulation of receptor activation by
nanoscale distribution of ligands nor the exact mechanism by which ephrin 
distribution is translated into biological information is understood. The DNA origami 
nanostructures combined with protein patterns of well-defined ephrin-A5 that we 
developed in this study formed a unique tool to probe the roles of spatial 
distribution of ligands on receptor activation and downstream signaling. 
Due to limitations in studying the nanoscale protein arrangements in cells, 
the sizes of ligand-receptor clusters remain unknown, but it has been suggested that 
transient macrodomains in the cell membrane, ranging between 10 and 200 nm in 
size, harbor signaling proteins. The DNA origami-based tool developed is a 140 nm 
long rod-like structure comprised of 18 double helices. We positioned recombinant 
ephrin-A5-Fc ligands on this rod, spaced 100 nm or 40 nm apart from one another, 
as seen in the transmission electron micrographs in Figure 5. Due to the precise 
ability for patterning of these ligands at the nanoscale, we named this tool ephrin-
A5 nano-calipers (NC). 
 
 
 
 
 
 
  
 
 
 
In order to study the effect of ephrin-A5 ligand distribution on Eph receptor signaling,
we made use of a highly invasive breast cancer cell line, MDA-MB-231, which 
overexpresses receptor EphA2. EphA2 is up-regulated in many aggressive cancers,
including breast cancer, where it promotes cell migration, and expression levels have 
been shown to correlate with tumor aggressiveness.
100
 Protein tyrosine
phosphorylation levels regulate adhesion between cells as well as between cells and 
the ECM, and elevated levels of tyrosine kinase weakens cell-cell contact and
increases adhesion to the ECM. Moreover, overexpression of EphA2 in non-
transformed mammary epithelial cells, MCF-10a, induces malignancy and 
tumorigenic potential.
101
 Of note, EphA2 has shown enzymatic activity independent 
Figure 5. Transmission electron microscopy images showing ephrin-A5 nano-calipers with ligand 
separation of !100 nm (A) and !40 nm (B). 
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of ligand binding.
102
  
Commonly used methods to study receptor activation include 
immunocytochemistry or immunoprecipitation followed by immunoblottting. 
Nevertheless, these methods do not have enough resolution to allow for discrimination 
between different levels of receptor activation. Therefore, we made use of an in situ 
proximity ligation assay (PLA). Using this method, we were able to specifically 
analyze EphA2 receptor activation through tyrosine phosphorylation events, which is 
the first step of receptor tyrosine kinase activation. Specifically, in this assay, the close 
proximity of EphA2 and phosphotyrosine was visualized as fluorescent dots, which 
allowed for quantification of Eph receptor activation levels. 
In addition to the sensitivity of the PLA, the strength of this assay in our study 
was the ability to quantify receptor phosphorylation on a single-cell level. Particularly, 
by culturing the MDA-MB-231 cells on fibronectin micropatterns, we could prevent 
endogenous activation of the Eph signaling pathway through cell-cell contact. Using 
this method, we found that receptor activation was indeed triggered by the ephrin-A5 
nano-calipers after 15 minutes of stimulation. Moreover, receptor activation by ephrin-
A5 spaced 40 nm apart (NC40) was higher than for ephrin-A5 spaced 100 nm apart 
(NC100). To investigate downstream signaling effects, we performed RNA 
sequencing, which showed that ephrin-A5 nano-calipers regulated the transcriptome 
and moreover, that there was a significant differential gene expression upon cell 
stimulation with NC100 and NC40.  
 
 
 
 
  
 
 
 
 
Further exploring the functional responses of cells treated with our ephrin-A5 
nano-calipers involved analysis of invasiveness by commonly used migration assays. 
Overnight stimulation of the MBA-MD-231 cells with the different ephrin-A5 nano-
calipers showed a significant decrease in invasiveness compared to control, and even 
more so for NC40 than for NC100, which could be correlated to the results from the 
PLA that showed higher receptor activation for NC40.  
Figure 6. The Ephrin-A5 Nano-Caliper Concept. Ligand-receptor clustering between adjacent cells 
(A) or regulated by the ephrin DNA origami tool (B). Differences in clustering have been suggested to 
lead to disparate cell outcomes. The tool developed in this study has the potential to investigate 
differences in nanoscale ligand-receptor interactions and downstream signaling events. 
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 The question we asked ourselves in the design of this study was: do receptors on 
one cell feel and respond to the ligand presentation on other cells? The general idea 
behind this question is illustrated in 6. Although the nano-caliper tool used here does not 
represent what really happens in the event of cell-cell contact and ligand-receptor 
binding, we are confident to say that we have shown that receptors monitor and respond 
to the spatial distribution of ligands on adjacent cells and that the resulting receptor 
clusters serve as guidance cues or biological switches that direct the cellular outcome.  
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CONCLUSIONS 
This thesis encompasses studies that make use of a diverse selection of materials, cell 
systems and signaling pathways. Despite the assorted approaches, all four papers are 
unified in their application of bioengineering to manipulate cell function in the hopes of 
gaining a deeper understanding of the roles of biophysical regulation of cell behavior. 
 FGF, Notch and Eph signaling are the three distinct pathways that this work has 
focused on. Despite their unique features, it is important to keep in mind that neither one 
of these pathways is isolated from one another or from other molecular events occurring 
within and among cells. Entangled crosstalk between signaling pathways is standard and 
contributes to diversity in cell outcomes. This kind of integration has been observed 
between FGF, Notch and Eph signaling.83,103 Importantly, there is a constant interplay of 
signals, be they physical or chemical, that vary over space and time in a cell-type 
dependent manner. This is fundamental in embryonic development, where a limited 
number of signaling pathways are used repeatedly to create a precise pattern of 
transcription in order to generate various cellular outcomes. As such, reutilization of 
Notch at two different developmental stages in the same cell can have two distinctly 
different effects. Addressing the issue of timing of signaling is of great importance 
when trying to recapitulate the in vivo microenvironment, since lineage restriction and 
other developmental steps in the embryo happen during very limited time windows. 
Controlling signal timing was the motivation behind Paper I and II, where we 
developed an entirely novel neural stem cell culture substrate, which more closely 
mimics growth factor signaling in the brain during development compared to routine 
laboratory methods.  
 Whether the body is in homeostasis or in a diseased state, mechanical stresses 
constantly bombard the system. From tissue dynamics by contraction and relaxation, to 
cellular cytoskeleton movement, down to single proteins moving in the lipid membrane, 
the cells in the body are in constant motion. Cells respond to biophysical forces in the 
same manner that they alter their reaction to biochemical stimuli depending on when, 
where and in which cell the signaling occurs. This means that incoming cues from the 
microenvironment can be translated into different cellular responses. Notably, the 
stiffness of tissues changes over time during embryonic development and in tumor 
progression. In light of this, the dynamics of elastic moduli must be investigated in order 
to understand and control cell function in this kind of environment. This was the goal of 
Paper III, where we aimed to link the stiffness of breast cancer tumors to Notch 
signaling and cell dynamics. Inhibiting Notch signaling in breast cancer treatment has 
already been tested in clinical trials. However, Notch inhibition in breast cancer patients 
remains problematic, partly due to the side effects that come when targeting a common 
pathway active in other cell types than just cancer cells, and partly because Notch may 
have tumor suppressive functions. Due to these difficulties, we sought to identify 
opportunities for cancer therapies that target the cancer cell/microenvironment interface 
instead of the Notch pathway itself. Our studies demonstrate that it is possible to target 
cancer cell or matrix dynamics, rather than Notch signaling directly, showing that this 
kind of therapy could be of great interest in the treatment of breast cancer. 
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 In addition to Notch, the Eph/ephrin signaling pathway offers another promising 
target in cancer therapy. One way this could be achieved is by blocking forward 
signaling using either kinase inhibitors or with antibodies or peptides as agonists or 
antagonists. Research shows, however, that the same Eph receptor can give rise to 
disparate outcomes104. It could thus be preferable to steer cell function by tuning 
Eph/ephrin signaling, rather than blocking the pathway all together. It has been 
suggested that receptors in cell membranes are poised to respond to the initial nanoscale 
spatial arrangement of ligands on adjacent cells and that small differences in this spatial 
arrangement could lead to disparate cellular responses.   
 With these hypotheses in mind, we developed a tool using DNA nanotechnology. 
This allowed us to study ephrin ligand and Eph receptor interactions in order to 
determine the effect of ligand spatial distribution on receptor activation and downstream 
events on a nanoscale. The method presented in Paper IV is to our knowledge the first 
that allows for ligand patterning with such precise control. An enormous strength of this 
novel tool is its ability to be used in 3D culture, since the molecules are used in soluble 
form. A vast amount of literature has been generated over the past decade that aims to 
understand physical regulation of cellular state and fate. With the advent of 3D cultures, 
and techniques being developed to study these, there are many knowledge gaps that can 
be filled in the near future. Elucidating the mechanisms involved in biophysical 
regulation of cell function is necessary to understand cellular dysfunction and diseases. 
3D cell cultures are likely to give results that more closely capture what happens in 
tissues in vivo. Therefore, we believe that the DNA origami-based tool developed here 
has great potential in future studies of signaling pathways. In addition, understanding the 
mechanisms underlying signaling diversity has the potential to be used in the 
development of cancer therapeutics.  
  With the accumulating evidence that cells sense and respond to physiological 
input in the microenvironment, scientists from different fields have come together to 
answer basic biological questions. A myriad of materials, techniques and engineering 
approaches are being exploited that aim at controlling cell function by mimicking 
various aspects of the natural biophysical microenvironment. Recapitulating the in vivo 
stem cell niche has great potential to further what is known about development and 
tissue regeneration. Likewise, studying the tumor microenvironment in the most realistic 
setting possible can shed light on biophysical mechanisms involved in tumorigenicity. 
This research can lead to enormous advancements in the development of cancer 
therapies.  
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